o2 optix

GLG News Analyses - Healthcare - Gerson Lehrman Group Councils | Solutions | Platform | About Us | Careers | Contact Us Client Login | Council Member Login GLG Home Page Healthcare Accounting& Financial Analysis Consumer Goods& Services Energy& Industrials Financial& Business Services Healthcare Legal, Economic& Regulatory Affairs Real Estate Technology,Media & Telecom Home > Healthcare > GLG News Healthcare Overview Leading Experts Study Groups GLG NewsSM Business of Medicine Cardiology Endocrinology Healthcare Services Infectious Disease Oncology Ophthalmology Orthopaedics GLGi Educational Events Industry Dictionary Popular Topics in Healthcare Biotech Industry Cardiology Clinical Research Diabetes Healthcare Consulting Managed Care Industry Medical Device Neurology Oncology Pharmaceutical Industry Subscribe to Updates in Healthcare By Email By RSS The Expertise Imperative and Compliance Technology Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities. This page may include content provided by Council Members, your access to which is subject to the Terms of Use. Find Out More Become a GLG Client Become a GLG Council Member Enroll Your Company Recent News in Healthcare Recent News by GLG Leaders What is a GLG Leader? April 24, 2008Advance in Small Cell Lung Cancer (SCLC)? Analysis of: Poniard reports positive results for lung cancer drug | www.cnbc.com Author: Kenneth Algazy, Clinical Professor of Medicine , University of Pennsylvania School of Medicine - CC Doubles survival BUT "comparator" arm is best supportive care. See http://investor.poniard.com/ReleaseDetail.cfm?ReleaseID=306218 April 24, 2008Corcept Therapeutics Takes Yet Another Shot at Psychotic Depression Analysis of: Corcept Therapeutics Announces Commencement Of Next Phase 3 Study With CORLUX(R) For The Treatment Of Psychotic Depression | www.biospace.com Author: Louis Sanfilippo, Scientific Advisor, Cenestra Health Corcept Therapeutics is at it again with yet another clinical trial for its lead candidate mifeprisotone (Corlux), a GR-II (glucocorticoid) receptor antagonist, hoping to show efficacy on the psychotic features of psychotic major depression (PMD). Corlux clearly offers a potentially novel paradigm unlike anything presently on the market for treating psychiatric disorders – it targets the... April 24, 2008Industry leaders need to work with the US Patent and Trademark office to keep US patents strong Analysis of: Federal Court Sides With GlaxoSmithKline, Strikes Down Rules Issued by Patent Office | biz.yahoo.com Author: Mark Tapsak, Assistant Professor, BLOOMSBURG UNIVERSITY OF PENNSYLVANIA INC The USPTO is facing an epidemic amount of frivolous patents. This degrades their ability to review strong and potentially important patents in a timely manner. Although this particular change was struck down in Federal court, industry leaders need to work with the USPTO in order to strengthen the US patent system. April 24, 2008COPAXONE from the START of MS Analysis of: Teva Seeks Approval for the Extension of its Indication to Include the Treatment of Patients with a First Clinical Event Suggestive of MS | www.pipelinereview.com Author: Daniel Wynn, Director, Clinical Research, Consultants In Neurology Ltd. Copaxone has become the leading treatment for relapsing remitting MS in the US. The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further. April 22, 2008Thalidomide (Celgene) use to be liberalized in Europe Analysis of: Thalidomide Gets Boost in Europe | online.wsj.com Author: Kenneth Algazy, Clinical Professor of Medicine , University of Pennsylvania School of Medicine - CC Thalidomide literally started the improved outlook in MM along with, and followed by Velcade, Revlimid and Stem Cell transplants. To now have increased access in Europe should open up that market eventhough the other agents are in widespread use (I think) All Recent Analyses Articles with lock require a subscription to GLG News | Request a free trial April 25, 2008Oral PBI-1402 from ProMetic Life Sciences Inc. Might Have the Potential to Fill the Void Left by the EPO Stimulating AgentsAnalysis of: Oral PBI-1402 Demonstrates Significant Activity in Chemeotherapy-Induced Anemia Phase II Clinical Trial | www.pipelinereview.comAuthor: GLG Expert ContributorWhile only a Phase II study, it suggest that Oral PBI-14 may be of significant help to cancer patients who suffer from anemia caused by their chemotherapy. http://www.pipelinereview.com/content/view/19152/109/ This is especially notable given the recent saftey concerns about and decline in use of Procrit and Aranesp - the only other drugs typically used to treat chemotherapy-induced ane... April 24, 2008IL-13 in asthmaAnalysis of: MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 | www.pipelinereview.comAuthor: GLG Expert ContributorThis is a better target than IL-5. But some of the issues are the same. April 24, 2008Stem cells for Mulitple SclerosisAnalysis of: Pluristem's PLX Cells Show a Statistically Significant Advantage in a Pre-Clinical Study in the Multiple Sclerosis Model | www.pipelinereview.comAuthor: GLG Expert ContributorThe battle between hype and hope continues. April 24, 2008Lexicon's drug for RAAnalysis of: Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows Positive Results in Phase 1 Clinical Trial | www.pipelinereview.comAuthor: GLG Expert ContributorTo call these result positive is to be very optimistic. April 24, 2008Cimzia in Crohn's DiseaseAnalysis of: CimziaA(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease | www.pipelinereview.comAuthor: GLG Expert ContributorAnother anti-TNF for Crohns Disease. How will it stack up against the competition? View More More GLG News inHealthcare Most Popular: Source Article | Expert Analyses CooperVision Introduces Avairaв„ў Two-Week Silicone Hydrogel Contact Lenseswww.coopervision.com Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancerjco.ascopubs.org Pluristem's PLX Cells Show a Statistically Significant Advantage in a Pre-Clinical Study in the Multiple Sclerosis Modelwww.pipelinereview.com MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 www.pipelinereview.com Study Suggests Gammagard Liquid May Target the Primary Pathway Involved in Alzheimer's Diseasebiz.yahoo.com XELOX=FOLFOX! Score one for Roche!April 18, 2008 Cooper Vision needs Avaira to be successful to maintain it's status in the Contact Lens IndustryApril 18, 2008 Startling New Evidence Suggests IVIg May Help Alzheimer's PatientsApril 18, 2008 CooperVision enters US market with Avairaв„ў two-week silicone hydrogel contact lensesApril 16, 2008 Injectable glaucoma drug vs. patient complianceApril 15, 2008 GLG News: What Experts Think Is ImportantRequest a free trial of GLG NewsYour email address © 2008 Gerson Lehrman Group. All Rights Reserved Terms of Use | Privacy Policy | Site Map | Site Index GLG Councils | GLG Institute | GLG News | GLG Research Management Platform разделы урок охота флаг башня корпаративные вечеринка новосельский доломит разогреть вчерашний обед профессиональный видеосъемка квантовый медицина бюро похоронный услуга урок охота охота лис зеркало babyliss мелованный бумага рефконтейнеры циклон сцн-40 управление иваново стальной топкий spartherm теннисный ракетка полноцвет кружок мужчина выходной компания доминике резка герб область авиа отправка залог кострома видеослот скачать длинный нард оформление свадеб лидо пекарня вакансия красноярск домашний очаг здоровье raymond weil залог кострома вытяжка лак краска купить стиральный купить стиральный вышивка флаг обрезание гиря торговый калибровочный автобетононасосы брэнд лад выборочный лак автошкола госпиталь мэш sky link спецобувь ванна моечный snr roulements отбеливание белье генерация кислорода билет цдкж сушильный машина frigidaire время владимир нужный билет детский лагерь пионер флюоресцентный краска лечение иглоукалыванием переводческий бюро доставка дров подгонный компенсатор danfoss слименд лифт меховой холодильник дирижабль de luxe 5040.11 откачка туалет подшипниковый узел кассовый машина бюро похоронный услуга асбест лак эмаль багетный мастерский устройство плавный пуск фосфорицирующая краска кайт пилотажный доставка ноутбук контакт контактор регестрация пбоюл тонирование окон билет балет жила кострома курьерский почта оповещение шапка доставка доломит сварочный пост съемный зубной протез билет балет mastercard предохранитель пкэ ipsec ароматный мир корпаративные вечеринка циклон цол перевод итальянский стопный пластырь купить блендер электрокамин dimplex model plasma (sp9) fargo заказать флаг крутой xxx видео телевизионный антенна магнитно-маркерные доска индустриальный монитор антенна радиочастотный o2 optix